GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » 3-Year EBITDA Growth Rate

Yunkang Group (HKSE:02325) 3-Year EBITDA Growth Rate : -60.70% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group 3-Year EBITDA Growth Rate?

Yunkang Group's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.20.

During the past 12 months, Yunkang Group's average EBITDA Per Share Growth Rate was -96.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -60.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 91.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Yunkang Group was 604.10% per year. The lowest was -60.70% per year. And the median was 165.90% per year.


Competitive Comparison of Yunkang Group's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Yunkang Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Yunkang Group's 3-Year EBITDA Growth Rate falls into.



Yunkang Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Yunkang Group  (HKSE:02325) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Yunkang Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Yunkang Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group (HKSE:02325) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines